These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 1786929)

  • 1. [Inhibition of cholesterol synthesis and cataract].
    Hockwin O; Kojima M; Czubayko F; von Bergmann K
    Fortschr Ophthalmol; 1991; 88(4):393-5. PubMed ID: 1786929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigations on the presence of 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMG-CoA-reductase, E.C.1.1.1.34) in lenses of various animal species.
    Kojima M; Hockwin O; Rao GS; Garcia J
    Lens Eye Toxic Res; 1990; 7(3-4):605-23. PubMed ID: 2100181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the etiology of subcapsular lenticular opacities produced in dogs receiving HMG-CoA reductase inhibitors.
    Gerson RJ; MacDonald JS; Alberts AW; Chen J; Yudkovitz JB; Greenspan MD; Rubin LF; Bokelman DL
    Exp Eye Res; 1990 Jan; 50(1):65-78. PubMed ID: 2307197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholesterol content of the rat lens is lowered by administration of simvastatin, but not by pravastatin.
    De Vries AC; Vermeer MA; Bredman JJ; Bär PR; Cohen LH
    Exp Eye Res; 1993 Apr; 56(4):393-9. PubMed ID: 8500554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of cholesterol synthesis by squalene synthase inhibitors does not induce myotoxicity in vitro.
    Flint OP; Masters BA; Gregg RE; Durham SK
    Toxicol Appl Pharmacol; 1997 Jul; 145(1):91-8. PubMed ID: 9221828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The eye lens evaluation of the atorvastatin-treated white rat.
    Zakrzewski P; Milewska J; Czerny K
    Ann Univ Mariae Curie Sklodowska Med; 2002; 57(2):165-71. PubMed ID: 12898835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of small GTP-binding proteins in lovastatin-induced cataracts.
    Rao PV; Robison WG; Bettelheim F; Lin LR; Reddy VN; Zigler JS
    Invest Ophthalmol Vis Sci; 1997 Oct; 38(11):2313-21. PubMed ID: 9344354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The synergistic hypocholesterolemic activity of the potent cholesterol absorption inhibitor, ezetimibe, in combination with 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors in dogs.
    Davis HR; Pula KK; Alton KB; Burrier RE; Watkins RW
    Metabolism; 2001 Oct; 50(10):1234-41. PubMed ID: 11586500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pravastatin--ocular side effects after a two year follow-up?
    Behrens-Baumann W; Thiery J; Fieseler HG; Seidel D
    Lens Eye Toxic Res; 1990; 7(3-4):311-8. PubMed ID: 2129219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ocular drug-safety study with the HMG-CoA reductase inhibitor pravastatin.
    Schmitt C; Schmidt J; Hockwin O
    Lens Eye Toxic Res; 1990; 7(3-4):631-42. PubMed ID: 2129220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Policosanol inhibits cholesterol synthesis in hepatoma cells by activation of AMP-kinase.
    Singh DK; Li L; Porter TD
    J Pharmacol Exp Ther; 2006 Sep; 318(3):1020-6. PubMed ID: 16714400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of cholesterol-lowering treatment in Japanese elderly patients with coronary artery disease and normal cholesterol level using 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor.
    Chikamori T; Sugimoto K; Hamada T; Kitaoka H; Furuno T; Seo H; Doi Y
    J Cardiol; 2000 Feb; 35(2):95-101. PubMed ID: 10713930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of early cholesterol biosynthesis in rat liver: effects of sterols, bile acids, lovastatin, and BM 15.766 on 3-hydroxy-3-methylglutaryl coenzyme A synthase and acetoacetyl coenzyme A thiolase activities.
    Honda A; Salen G; Nguyen LB; Xu G; Tint GS; Batta AK; Shefer S
    Hepatology; 1998 Jan; 27(1):154-9. PubMed ID: 9425931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-mortem biochemistry of beagle dog lenses after treatment with Fluvastatin (Sandoz) for 2 years at different dose levels.
    Hockwin O; Evans M; Roberts SA; Stoll RE
    Lens Eye Toxic Res; 1990; 7(3-4):563-75. PubMed ID: 2151608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The HMG-CoA reductase inhibitors simvastatin and pravastatin. No indication for side effects in use on humans].
    Schmidt J; Schmitt C; Hockwin O
    Fortschr Ophthalmol; 1991; 88(6):843-5. PubMed ID: 1794817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subchronic toxicity of atorvastatin, a hydroxymethylglutaryl-coenzyme A reductase inhibitor, in beagle dogs.
    Walsh KM; Albassam MA; Clarke DE
    Toxicol Pathol; 1996; 24(4):468-76. PubMed ID: 8864188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lens cholesterol biosynthesis inhibition: A common mechanism of cataract formation in laboratory animals by pharmaceutical products.
    Aleo MD; Doshna CM; Baltrukonis D; Fortner JH; Drupa CA; Navetta KA; Fritz CA; Potter DM; Verdugo ME; Beierschmitt WP
    J Appl Toxicol; 2019 Sep; 39(9):1348-1361. PubMed ID: 31231834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholesterol synthesis inhibitors inhibit more than cholesterol synthesis.
    Kasiske BL; O'Donnell MP; Kim Y; Atluru D; Keane WF
    Kidney Int Suppl; 1994 Feb; 45():S51-3. PubMed ID: 8158898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atorvastatin is not cataractogenic in beagle dogs.
    Robertson DG; Urda ER; Rothwell CE; Walsh KM
    Curr Eye Res; 1997 Dec; 16(12):1229-35. PubMed ID: 9426956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HMG CoA reductase inhibitor-induced myotoxicity: pravastatin and lovastatin inhibit the geranylgeranylation of low-molecular-weight proteins in neonatal rat muscle cell culture.
    Flint OP; Masters BA; Gregg RE; Durham SK
    Toxicol Appl Pharmacol; 1997 Jul; 145(1):99-110. PubMed ID: 9221829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.